Latest Regulatory News

Page 215 of 632
Bio-Gene Technology’s novel acaricide Flavocide demonstrated over 90% mortality against Lyme disease-carrying ticks in lab tests presented by Purdue University, highlighting its potential in public health applications.
Ada Torres
Ada Torres
23 Sept 2025
Maronan Metals Limited has had its trading suspension lifted immediately following the release of its Preliminary Economic Assessment, signaling renewed market activity.
Maxwell Dee
Maxwell Dee
23 Sept 2025
MetalsTech Limited has completed a significant off-market block trade involving 4 million shares worth nearly $2 million, signaling notable shifts among its substantial shareholders.
Maxwell Dee
Maxwell Dee
23 Sept 2025
Klevo Rewards Limited has initiated a non-renounceable entitlement offer to raise up to $4.1 million by issuing new shares at $0.009 each, inviting existing shareholders to participate by 1 October 2025.
Sophie Babbage
Sophie Babbage
23 Sept 2025
Arovella Therapeutics has received a $3.21 million R&D tax incentive refund, bolstering its financial position as it prepares to initiate first-in-human trials for its lead cell therapy, ALA-101.
Ada Torres
Ada Torres
23 Sept 2025
Amplitude Energy Limited has announced a fully underwritten $150 million equity raising to fund the expansion of its East Coast Supply Project (ECSP+) and the potential restart of the Patricia Baleen gas field, aiming to boost gas supply in Australia’s constrained east coast market.
Maxwell Dee
Maxwell Dee
23 Sept 2025
Amplitude Energy is expanding its East Coast Supply Project by adding a fourth well at the Nestor prospect and plans a potential restart of the Patricia Baleen field, supported by a $150 million equity raising to fund these growth initiatives.
Maxwell Dee
Maxwell Dee
23 Sept 2025
Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.
Victor Sage
Victor Sage
23 Sept 2025
The European Medicines Agency has approved continuous bi-monthly dosing of CLINUVEL’s SCENESSE® for adult erythropoietic protoporphyria patients, removing previous annual dose limits and aligning Europe with US treatment standards.
Victor Sage
Victor Sage
23 Sept 2025
Sprintex Limited has secured a significant A$16.6 million order to supply integrated control systems for Mest Water’s innovative manure processing units, marking a major step in sustainable agriculture technology in the Netherlands.
Victor Sage
Victor Sage
23 Sept 2025
Clover Corporation posted a robust 38% revenue increase to $86 million in FY25, driven by product innovation and operational gains, while declaring a final dividend. The company’s cautious outlook for FY26 reflects ongoing regulatory and production challenges.
Victor Sage
Victor Sage
23 Sept 2025
Nuix Limited has showcased its strategic AI-driven growth plan centered on the Nuix Neo Platform and Deep Learning Framework, promising enhanced data processing and new regulatory solutions in FY26.
Sophie Babbage
Sophie Babbage
23 Sept 2025